Servicio
de Apoyo Científico-Técnico al Profesional
Adquisición de nuevos libros
Los siguientes libros han ingresado en la colección del SACT:
• Dacie and Lewis practical haematolgy /S. Mitchell Lewis, Barbara J. Brain, Imelda Bates. – 10th ed. – Philadelphia, PA. Editorial Elsevier Ltd. 2006. – xiii, 722p: il. col.: 23,5 x 19 cm.
Contiene: - Collection and handling of blood. – Reference ranges and normal values. – Basic haematological techniques. – Preparation and staining methods for blood and bone marrow films. – Blood cell morphology in health and disease. – Bone marrow biopsy. – Iron deficiency anaemia and iron overload. – Investigation of megaloblastic anaemia-cobalamin, folate, and metabolite status. – Laboratory methods used in the investigation of the haemolytic anaemias. – Investigation of the hereditary haemolytic anaemias< membrane and enzyme abnormalities. – Acquired haemolytic anaemias. – Investigation of abnormal haemoglobins and thalassaemia. – Erythrocyte and leucocyte cytochemistry. – Diagnostic radioisotopes in haematology. – Investigation of haemostasis. – Investigation of a thrombotic tendency. – Laboratory control of anticoagulant, thrombolytic, and antiplatelet therapy. – Blood cell antigens and antibodies: erythrocytes, platelets, and granulocytes 481. – Laboratory aspects of blood transfusion. – Molcular and cytogenetic analysis. – Miscellaneous tests. – Approach to the diagnosis and classification of blood diseases. – Laboratory organization and management. - Laboratory safety. – Quality assurance. – Haematology in under-resourced laboratories.
• Cardiovascular biomarkers / David A. Marrow – Totowa, New Jersey. Editorial Human Press Inc. 2006 – xvii, 620p : il. col. : 26 x 18,5 cm.
Contiene: Biomarkers of myocardial necrosis: past, present, and future. – Analytical issue for the clinical use of cardiac troponin. – Definig myocardial infarction. – Biomarkers in the emergency department: rapid diagnosis and triage. – Cardiac troponin for risk assessment and management of non-ST-elevation acute coronary syndrome. – Biomarkers of necrosis for risk assessment and management of ST-elevation myocardial infarction. – Cardiac troponin after revascularization procedures. – Biomarkers of necrosis in heart failure: past present, and future directions. – Is there a role for cardiac troponin and other biomarkers in patients with pulmonary embolism?. – Cardiac troponin in conditions others than acute coronary syndromes. – Degradation of cardiac troponins: implications for clinical practice. – Developing a marker of ischemia: Clinical and research challenges. – Emerging biomarkers of myocardial ischemia. – Inflammation in cardiovascular disease: the biological basis of inflammatory biomarkers. – Analytic issues for the clinical use of C-reactive protein. – C-reactive protein as a tool for risk assessment in primary prevention. - High-sensitivity c-reactive protein for risk assessment in acute coronary syndromes. – Beyond c-reactive protein: novel markers of vascular inflammation. – Biomarkers of inflammation: implications in patients with heart failure. – Biomarkers of infection and risk of coronary heart disease. – Biology of the natriuretic peptides. – Analytic issues for the clinical use of B-type natriuretic peptide. – Clinical use of natriuretic peptides for the diagnosis and management of heart failure. – Natriuretic peptides in acute and chronic coronary artery disease. – Novel markers of hemodynamic stress. – Clinical and research applications of markers of thrombosis. – Measures of platelet activation and aggregation. – Monocyte-platelet aggregates in patient with ischemic heart disease. – Measurement of atherogenic lipoproteins in cardiovascular risk assessment. – Lipoprotein-associated phospholipase A2 and other lipid-realted biomarkers in cardiovascular disease. – A multimarker approach to evaluation of patients with acute coronaty syndrome. – Cardiac biomarkers by point-of-care testing. – Proteomics and cardiovascular biomarker discovery. – Genetic markers in cardiovascular disease.
|
|
